Source: International Congress 2016 – Common mechanisms in lung development and fibrosis
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Audrey Joannes (Paris, France), Audrey Joannes, Madeleine Jaillet, Arnaud Mailleux, Bruno Crestani. LSC Abstract – Activation of FGF9 and 18 in idiopathic pulmonary fibrosis promote survival and migration and inhibit myofibroblast differentiation of human lung fibroblasts. Eur Respir J 2016; 48: Suppl. 60, 4031

Member's Comments

No comment yet.

Related content which might interest you: Reactivation of developmental pathways in idiopathic pulmonary fibrosis: FGF9 and FGF18 modulate the phenotype of control and fibrotic human lung fibroblasts in vitro Source: International Congress 2015 – IPF: from bench to bedside Year: 2015 NOX4/NADPH oxidase expression is increased in pulmonary fibroblasts from patients with idiopathic pulmonary fibrosis and mediates TGFβ1-induced fibroblast differentiation into myofibroblasts Source: Annual Congress 2009 - From emphysema to fibrosis: mechanisms of cellular remodelling in the diseased lung Year: 2009 Fibroblast growth factor 9 (FGF9) modulates mesothelial cells plasticity to decrease differentiation and migration in vitro Source: International Congress 2016 – Common mechanisms in lung development and fibrosis Year: 2016 IL-11 promotes pulmonary vascular remodeling and lung fibrosis through the activation of endothelial to mesenchymal transition. Source: Virtual Congress 2020 – Translational aspects of idiopathic pulmonary fibrosis Year: 2020 Regulation and role of notch signaling in epithelial progenitor cell differentiation and proliferation in the normal and the fibrotic lung Source: Annual Congress 2013 –Idiopathic pulmonary fibrosis: pathogenesis Year: 2013 Primary human airway epithelial cells inhibit proliferation of lung fibroblasts via transforming growth factor-β Source: Annual Congress 2007 - Acute and chronic lung injury and its repair: novel molecular insight Year: 2007 Expression of Smad proteins during myofibroblast differentiation in pulmonary fibrosis Source: Eur Respir J 2005; 26: Suppl. 49, 267s Year: 2005 Epidermal growth factor receptor (EGFR) activation is required for TGFbeta1-induced epithelial-mesenchymal transition (EMT) in idiopathic pulmonary fibrosis (IPF) Source: Annual Congress 2013 –Growth factors at the crossroads of acute and chronic inflammation Year: 2013 Wnt11 inhibits effects of transforming growth factor-beta1 (TGFbeta1) on lung epithelial phenotype Source: Annual Congress 2013 –Growth factors at the crossroads of acute and chronic inflammation Year: 2013 Inhibition of the Arp2/3 complex inhibits lung myofibroblast differentiation in vitro and attenuates bleomycin-induced pulmonary fibrosis in mice Source: International Congress 2019 – Extracellular matrix formation and remodelling in physiology and disease Year: 2019 Fibroblast growth factor 9 (FGF9) modulates the phenotype of control and fibrotic human lung fibroblasts in vitro Source: International Congress 2014 – New and old players in fibrotic lung disease Year: 2014 Mesenchymal stem cells isolated from fibrotic human lung tissue inhibit collagen expression by lung fibroblasts Source: International Congress 2016 – ILD: from the bench to the bedside Year: 2016 Synergistic role of HSP90a and HSP90ß to promote myofibroblast persistence in lung fibrosis Source: Eur Respir J, 51 (2) 1700386; 10.1183/13993003.00386-2017 Year: 2018 Altered phenotype of COPD primary fibroblasts from airway and alveolar tissues: proliferation and apoptosis. Source: International Congress 2019 – Research and innovation in airway diseases Year: 2019 Dickkopf proteins influence lung epithelial cell proliferation in idiopathic pulmonary fibrosis Source: Eur Respir J 2011; 37: 79-87 Year: 2011 Role of Bcl-xL in hepatocyte growth factor elicited epithelial protection in idiopathic lung fibrosis Source: Annual Congress 2013 –Idiopathic pulmonary fibrosis: pathogenesis Year: 2013 Cell specific gene transfer of hepatocyte growth factor reduces bleomycin-induced lung fibrosis by inhibition of partial EMT Source: Annual Congress 2008 - Vascular and interstitial remodelling in chronic lung disease: therapeutic interventions on the horizon Year: 2008 BIBF1120 inhibits fibroblasts proliferation and production of the extracellular matrix protein fibulin-1 Source: International Congress 2015 – Pulmonary fibrosis: mechanisms of disease Year: 2015 Bromodomain inhibitor JQ1 attenuates TGF-beta-suppressed SOD2 expression and reduces proliferation in human primary pulmonary fibroblasts Source: Annual Congress 2013 –The multiple faces of stress in lung injury Year: 2013 Upregulation of Fas-signalling molecules in lung epithelial cells from patients with idiopathic pulmonary fibrosis Source: Eur Respir J 2001; 17: 180-189 Year: 2001